Skip to main content

Table 1 Clinical demographics

From: The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma

Patient

Age

Gender

Diagnosis

Catheter(s) tip placement area

1

49

M

Glioblastoma

Non-contrast and contrast enhancing

2

68

M

Glioblastoma

Non-contrast enhancing

3

32

M

Glioblastoma

Non-contrast and contrast enhancing

4

60

M

Glioblastoma

Non-contrast enhancing

5

51

M

Glioblastoma

Non-contrast enhancing

6

70

F

Glioblastoma

Non-contrast enhancing

  1. All patients diagnosed with recurrent glioblastoma and catheter tips were placed in non-contrast enhancing tumor. In patients 1 and 3, tips were also placed in contrast enhancing tissue